Xenetic Biosciences (XBIO) Total Debt (2011 - 2016)
Xenetic Biosciences' (XBIO) quarterly Total Debt came in at $152529.0 in Q3 2016, down 94.58% YoY from $2.8 million in Q4 2015, and little changed on a QoQ basis from $152529.0 in Q2 2016.
Xenetic Biosciences (XBIO) Total Debt (2011 - 2016) Analysis & Trends
Xenetic Biosciences (XBIO) has 6 years of Total Debt data on file, last reported at $152529.0 in Q3 2016.
- Quarterly Total Debt fell 94.58% year-over-year to $152529.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $152529.0 (down 94.58% YoY) and the FY2015 annual result came in at $395000.0, changed 0.0% from the prior year.
- Total Debt held at $152529.0 in Q3 2016, from $152529.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $7.0 million in Q1 2016 to a low of $152529.0 in Q2 2016.
- A 5-year average of $823149.6 and a median of $395000.0 in 2014 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 1672.91% in 2016, down 94.58% in 2016.
- Tracing XBIO's Total Debt over 5 years: stood at $212813.0 in 2012, then soared by 150.37% to $532813.0 in 2013, then declined by 25.87% to $395000.0 in 2014, then changed by 0.0% to $395000.0 in 2015, then slumped by 61.39% to $152529.0 in 2016.
- The last three Total Debt figures came in at $152529.0 (Q3 2016), $152529.0 (Q2 2016), and $7.0 million (Q1 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Xenetic Biosciences | 7.59 Mn | 1.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 152,529.00 |
| Jun 30, 2016 | 152,529.00 |
| Mar 31, 2016 | 7.00 Mn |
| Dec 31, 2015 | 395,000.00 |
| Sep 30, 2015 | 2.81 Mn |
| Jun 30, 2015 | 395,000.00 |
| Mar 31, 2015 | 395,000.00 |
| Dec 31, 2014 | 395,000.00 |
| Sep 30, 2014 | 395,000.00 |
| Jun 30, 2014 | 626,042.00 |
| Mar 31, 2014 | 681,042.00 |
| Nov 30, 2013 | 532,813.00 |
| Aug 31, 2013 | 425,626.00 |
| May 31, 2013 | 212,813.00 |
| Feb 28, 2013 | 212,813.00 |
| Nov 30, 2012 | 212,813.00 |
| Aug 31, 2012 | 212,813.00 |
| May 31, 2012 | 212,813.00 |
| Feb 29, 2012 | 212,813.00 |
| Aug 31, 2011 | 212,813.00 |